Literature DB >> 9528836

Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.

A G Remacle1, A Noël, C Duggan, E McDermott, N O'Higgins, J M Foidart, M J Duffy.   

Abstract

Matrix metalloproteinases (MMPs) are zinc dependent endopeptidases implicated in cancer invasion and metastasis. Gelatin zymography was performed on 84 human breast carcinomas and seven normal breast tissues. The precursor form of MMP-2 (72 kDa) was found in 11 (12%) samples, while its two activated forms, i.e. 62 kDa and 59 kDa, were found in three (6%) and 34 (40%) samples respectively. In contrast to MMP-2, most of the samples (52%) contained MMP-9 in its precursor form. Using ELISA, MMP-1 levels were found in 12% of the samples while MMP-3 levels were found in only 2% of the samples. Levels of MMP-2, -3 and -9 correlated inversely with numbers of nodal metastases. Neither MMP-2 nor -9 levels were significantly related to patient outcome. However, patients with high levels of a 50-kDa gelatinase band after zymography had a significantly better survival than patients with low levels. This species was never observed in normal breast tissue.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528836      PMCID: PMC2150110          DOI: 10.1038/bjc.1998.153

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  38 in total

1.  Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase.

Authors:  M Höyhtyä; E Hujanen; T Turpeenniemi-Hujanen; U Thorgeirsson; L A Liotta; K Tryggvason
Journal:  Int J Cancer       Date:  1990-08-15       Impact factor: 7.396

2.  Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases.

Authors:  O A Alvarez; D F Carmichael; Y A DeClerck
Journal:  J Natl Cancer Inst       Date:  1990-04-04       Impact factor: 13.506

3.  Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells.

Authors:  Y A De Clerck; T D Yean; B J Ratzkin; H S Lu; K E Langley
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

4.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

5.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

Authors:  C Monteagudo; M J Merino; J San-Juan; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

6.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.

Authors:  P D Brown; A T Levy; I M Margulies; L A Liotta; W G Stetler-Stevenson
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

7.  Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression.

Authors:  K S Lee; S Y Rha; S J Kim; J H Kim; J K Roh; B S Kim; H C Chung
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

8.  Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  J M Chen; R T Aimes; G R Ward; G L Youngleib; J P Quigley
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

9.  Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies.

Authors:  M J Duffy; L O'Siorain; B Waldron; C Smith
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

Review 10.  Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.

Authors:  J R MacDougall; L M Matrisian
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

View more
  23 in total

1.  Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe.

Authors:  Walter J Akers; Baogang Xu; Hyeran Lee; Gail P Sudlow; Gregg B Fields; Samuel Achilefu; W Barry Edwards
Journal:  Bioconjug Chem       Date:  2012-02-29       Impact factor: 4.774

2.  Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.

Authors:  M E Kupferman; M E Fini; W J Muller; R Weber; Y Cheng; R J Muschel
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

3.  Near-infrared triple-helical peptide with quenched fluorophores for optical imaging of MMP-2 and MMP-9 proteolytic activity in vivo.

Authors:  Xuan Zhang; Jamee Bresee; Gregg B Fields; W Barry Edwards
Journal:  Bioorg Med Chem Lett       Date:  2014-07-05       Impact factor: 2.823

4.  Production of bioengineered cancer tissue constructs in vitro: epithelium-mesenchyme heterotypic interactions.

Authors:  C S Wang; F Goulet; F Auger; N Tremblay; L Germain; B Têtu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

5.  Proteolysis in human breast cancer.

Authors:  E A Garbett; M W Reed; T J Stephenson; N J Brown
Journal:  Mol Pathol       Date:  2000-04

6.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

Review 7.  Contribution of p53 to metastasis.

Authors:  Emily Powell; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Cancer Discov       Date:  2014-03-21       Impact factor: 39.397

8.  Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma.

Authors:  S Samantaray; R Sharma; T K Chattopadhyaya; S Datta Gupta; R Ralhan
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-16       Impact factor: 4.553

9.  Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival.

Authors:  Ferhat Ozden; Caner Saygin; Didem Uzunaslan; Bulent Onal; Haydar Durak; Hilal Aki
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-25       Impact factor: 4.553

10.  Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.

Authors:  Rita C S Figueira; Luciana R Gomes; João S Neto; Fabricio C Silva; Ismael D C G Silva; Mari C Sogayar
Journal:  BMC Cancer       Date:  2009-01-14       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.